Growth is an extraordinarily complex biological phenomenon, requiring the coordinated production of multiple hormones and growth factors. The dramatic variation in size evident on earth graphically demonstrates how the forces of natural selection shape the . GH = Growth hormone; STAT = signal transducer and activator of transcription; JAK = Janus kinase; CIS = cytokine-induced SH2-containing protein; FAK = focal adhesion kinase; GAS = g-interferon-activated sites; GHRE = GH response element; GRB = growth factor receptor-bound protein; IRS = insulin receptor substrate; MEK, APK, ERK = mitogen-activated kinases; RAS = small GTP-binding protein; SHC = sh2-containing collagen-related protein; F = transcription factor.
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Growth is an extraordinarily complex biological phenomenon, requiring the coordinated production of multiple hormones and growth factors. The dramatic variation in size evident on earth graphically demonstrates how the forces of natural selection shape the . GH = Growth hormone; STAT = signal transducer and activator of transcription; JAK = Janus kinase; CIS = cytokine-induced SH2-containing protein; FAK = focal adhesion kinase; GAS = g-interferon-activated sites; GHRE = GH response element; GRB = growth factor receptor-bound protein; IRS = insulin receptor substrate; MEK, APK, ERK = mitogen-activated kinases; RAS = small GTP-binding protein; SHC = sh2-containing collagen-related protein; F = transcription factor. growth of different organisms. Human growth is characterized by several distinct features, including: (1) rapid growth in late gestation; (2) growth deceleration immediately following birth; (3) a prolonged childhood and a mid-childhood growth spurt; (4) a pubertal growth spurt; (5) relatively late attainment of adult height, and (6) minimal sexual dimorphism of adult stature. Secular changes in the height of humans probably reflect nutritional and environmental factors, rather than major genomic changes. Over the last century, the most dramatic changes in stature have been found in Third-World countries that have demonstrated improvements in nutrition, sanitation and the control of infectious diseases.
While multiple hormones impact growth, the growth hormone (GH)-insulin-like growth factor (IGF) axis plays a central role in both intrauterine and postnatal growth. Growth hormone, after being secreted by the pituitary, binds to a transmembrane receptor and activates a post-receptor-signaling cascade, ultimately leading to phosphorylation of signal transducer and activator of transcription (STAT) 5b. STAT5b transcriptionally regulates the genes for IGF-1 and for key IGF-binding proteins. IGF-1, in turn, binds to the type 1 IGF receptor, resulting in chondrocyte proliferation and statural growth. IGF-deficient states may be divided into secondary forms, reflecting defects in GH production, and primary forms. Molecular defects of the GH-IGF axis have been identified in humans, with phenotypes that correspond to the specific genetic lesions. Therapy with GH or IGF-1 can now be matched to specific defects in the GH-IGF axis, opening up the possibilities of a 'personalized medicine' approach to growth disorders (table 1) .
